Update Alert 6: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

Systematic review was updated to include several new studies. Findings from one observational study found no association with ACEi or ARB use and risk of COVID-19, and 11 other studies found no association with these drugs and worse outcomes in COVID-19.

Annals of Internal Medicine